{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:16:19Z","timestamp":1788275779243,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02795-1","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:48:23Z","timestamp":1788274103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the therapeutic response to sodium-glucose cotransporter-2 inhibition in INSR-related insulin resistance monogenic diabetes: case-based analysis and narrative review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2450-5126","authenticated-orcid":false,"given":"David","family":"Franklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6374-5224","authenticated-orcid":false,"given":"Chirag","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6811-1593","authenticated-orcid":false,"given":"Jessica","family":"Triay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"9","key":"2795_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.5694\/mja2.52717","volume":"223","author":"SM De Sousa","year":"2025","unstructured":"De Sousa SM, Davis TM, Harraway J, Greenslade M, Wu KH, Paul RG, Taylor J, Ali AS, Ekinci EI, Murphy R, Greenfield J (2025) Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults. Med J Aust 223(9):484\u2013491. https:\/\/doi.org\/10.5694\/mja2.52717","journal-title":"Med J Aust"},{"key":"2795_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","volume":"53","author":"BM Shields","year":"2010","unstructured":"Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504\u20132508. https:\/\/doi.org\/10.1007\/s00125-010-1799-4","journal-title":"Diabetologia"},{"issue":"2","key":"2795_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00592-023-02193-x","volume":"61","author":"SM De Sousa","year":"2023","unstructured":"De Sousa SM, Wu KH, Colclough K, Rawlings L, Dubowsky A, Monnik M, Poplawski N, Scott HS, Horowitz M, Torpy DJ (2023) Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing. Acta Diabetol 61(2):181\u2013188. https:\/\/doi.org\/10.1007\/s00592-023-02193-x","journal-title":"Acta Diabetol"},{"issue":"12","key":"2795_CR4","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2337\/dci20-0065","volume":"43","author":"MC Riddle","year":"2020","unstructured":"Riddle MC, Philipson LH, Rich SS, Carlsson A, Franks PW, Greeley SAW, Nolan JJ, Pearson ER, Zeitler PS, Hattersly AT (2020) Monogenic diabetes: from genetic insights to population-based precision in care. Reflections from a Diabetes Care editors\u2019 expert forum. Diabetes Care 43(12):3117\u20133128. https:\/\/doi.org\/10.2337\/dci20-0065","journal-title":"Diabetes Care"},{"key":"2795_CR5","doi-asserted-by":"publisher","first-page":"606964","DOI":"10.3389\/fendo.2021.606964","volume":"12","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Yu J, Yuan X, Wang C, Zhu Z, Zhang A, Gu W (2021) Clinical and functional characterization of novel INSR variants in two families with severe insulin resistance syndrome. Front Endocrinol 12:606964. https:\/\/doi.org\/10.3389\/fendo.2021.606964","journal-title":"Front Endocrinol"},{"key":"2795_CR6","unstructured":"Mesika A, Klar A, Falik Zaccai TC (2024) INSR-related severe insulin resistance syndrome. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae Seattle (WA): University of Washington, Seattle. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK476444\/"},{"issue":"5","key":"2795_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/jdi.12824","volume":"9","author":"Z Huang","year":"2018","unstructured":"Huang Z, Liu J, Ng K, Wan X, Xu L, He X, Liao Z, Li Y (2018) Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene. J Diabetes Invest 9(5):1075\u20131083. https:\/\/doi.org\/10.1111\/jdi.12824","journal-title":"J Diabetes Invest"},{"key":"2795_CR8","unstructured":"Padda IS, Mahtani AU, Parmar M (2025) Sodium-Glucose Transport 2 (SGLT2) Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576405\/"},{"issue":"1","key":"2795_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/diaclin.32.1.4","volume":"32","author":"EC Chao","year":"2014","unstructured":"Chao EC (2014) SGLT-2 inhibitors: a new mechanism for glycemic control. Clin Diabetes 32(1):4\u201311. https:\/\/doi.org\/10.2337\/diaclin.32.1.4","journal-title":"Clin Diabetes"},{"key":"2795_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.18773\/austprescr.2020.049","volume":"5","author":"T Chesterman","year":"2020","unstructured":"Chesterman T, Thynne TR (2020) Harms and benefits of sodium-glucose co-transporter 2 inhibitors. Australian Prescriber 5:168\u2013171. https:\/\/doi.org\/10.18773\/austprescr.2020.049","journal-title":"Australian Prescriber"},{"issue":"4","key":"2795_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1096\/fj.201700442R","volume":"32","author":"R Kj\u00f8bsted","year":"2018","unstructured":"Kj\u00f8bsted R, Hingst JR, Fentz J, Foretz M, Sanz M, Pehm\u00f8ller C, Shum M, Maretti A, Mounier R, Treebak JT, Wojtaszewski JFP, Viollet B, Lantier L (2018) AMPK in skeletal muscle function and metabolism. FASEB J 32(4):1741\u20131777. https:\/\/doi.org\/10.1096\/fj.201700442R","journal-title":"FASEB J"},{"issue":"1","key":"2795_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2013.37.1.1","volume":"37","author":"HM O\u2019Neill","year":"2013","unstructured":"O\u2019Neill HM (2013) AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes Metabolism J 37(1):1\u201321. https:\/\/doi.org\/10.4093\/dmj.2013.37.1.1","journal-title":"Diabetes Metabolism J"},{"issue":"53","key":"2795_CR13","doi-asserted-by":"publisher","first-page":"44121","DOI":"10.1074\/jbc.M112.361386","volume":"287","author":"JO Lee","year":"2012","unstructured":"Lee JO, Lee SK, Kim JH, Kim N, You GY, Moon JW, Kim SJ, Park SH, Kim HS (2012) Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl\/CAP signaling in 3T3-L1 preadipocyte cells. J Biol Chem 287(53):44121\u201344129. https:\/\/doi.org\/10.1074\/jbc.M112.361386","journal-title":"J Biol Chem"},{"issue":"9","key":"2795_CR14","first-page":"968","volume":"93","author":"M Kasuga","year":"1992","unstructured":"Kasuga M, Kishimoto M, Hashiramoto M, Yonezawa K, Kazumi T, Hagino H, Shii K (1992) Insulin receptor Arg1131\u00e0Gln: a novel mutation in the catalytic loop of insulin receptor observed in insulin resistant diabetes. Nihon Geka Gakkai Zasshi 93(9):968\u2013971","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"2795_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00592-022-01972-2","volume":"60","author":"N Rapini","year":"2022","unstructured":"Rapini N, Patera PI, Schiaffini R, Ciampalini P, Pampanini V, Cristina MM, Deodati A et al (2022) Monogenic diabetes clinic (MDC): 3-year experience. Acta Diabetol 60:61\u201370. https:\/\/doi.org\/10.1007\/s00592-022-01972-2","journal-title":"Acta Diabetol"},{"key":"2795_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1753-0407.12797","volume":"11","author":"K Takasawa","year":"2019","unstructured":"Takasawa K, Tsuji-Hosokawa A, Takishima S, Wada Y, Nagasaki K, Dateki S, Numakura C et al (2019) Clinical characteristics of adolescent cases with Type A insulin resistance syndrome caused by heterozygous mutations in the \u03b2\u2010subunit of the insulin receptor (INSR) gene. J Diabetes 11:46\u201354. https:\/\/doi.org\/10.1111\/1753-0407.12797","journal-title":"J Diabetes"},{"key":"2795_CR17","doi-asserted-by":"publisher","unstructured":"Krishnamurthy M, Pingul MM (2016) A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism. J Pediatr Endocrinol Metab 29(10). https:\/\/doi.org\/10.1515\/jpem-2015-0384","DOI":"10.1515\/jpem-2015-0384"},{"issue":"1","key":"2795_CR18","doi-asserted-by":"publisher","first-page":"e2021055671","DOI":"10.1542\/peds.2021-055671","volume":"150","author":"A Galderisi","year":"2022","unstructured":"Galderisi A, Tamborlane W, Taylor SI, Attia N, Moretti C, Barbetti F (2022) SGLT2i improves glycemic control in patients with congenital severe insulin resistance. Pediatrics 150(1):e2021055671. https:\/\/doi.org\/10.1542\/peds.2021-055671","journal-title":"Pediatrics"},{"issue":"5","key":"2795_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/jdi.13241","volume":"11","author":"S Nagashima","year":"2020","unstructured":"Nagashima S, Wakabayashi T, Saito N, Takahashi M, Okada K, Ebihara K, Ishibashi S (2020) Long-term efficacy of the sodium\u2013glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome. J Diabetes Invest 11(5):1363\u20131365. https:\/\/doi.org\/10.1111\/jdi.13241","journal-title":"J Diabetes Invest"},{"key":"2795_CR20","doi-asserted-by":"publisher","first-page":"838887","DOI":"10.3389\/fendo.2022.838887","volume":"13","author":"JI Mart\u00ednez-Montoro","year":"2022","unstructured":"Mart\u00ednez-Montoro JI, Pinz\u00f3n-Mart\u00edn JL, Damas-Fuentes M, Fern\u00e1ndez-Valero J, Tinahones FJ (2022) Combination therapy with semaglutide and dapagliflozin as an effective approach for the management of type A insulin resistance syndrome: a case report. Front Endocrinol 13:838887. https:\/\/doi.org\/10.3389\/fendo.2022.838887","journal-title":"Front Endocrinol"},{"key":"2795_CR21","doi-asserted-by":"publisher","first-page":"1552690","DOI":"10.3389\/fendo.2025.1552690","volume":"16","author":"J Chrzanowska","year":"2025","unstructured":"Chrzanowska J, Lachowska J, Weimann M, Zubkiewicz-Kucharska A, Fornalczyk K, Kilis-Pstrusinska K, Smigiel R (2025) Case report: The long-term effects of empagliflozin therapy on glycemia and renal function in a patient with Rabson\u2013Mendenhall syndrome caused by two heterozygous variants in INSR gene. Front Endocrinol 16:1552690. https:\/\/doi.org\/10.3389\/fendo.2025.1552690","journal-title":"Front Endocrinol"},{"key":"2795_CR22","doi-asserted-by":"publisher","first-page":"1414451","DOI":"10.3389\/fgene.2024.1414451","volume":"15","author":"R Foglino","year":"2024","unstructured":"Foglino R, Barbetti F, Morotti E, Castorani V, Rigamonti A, Frontino G, Barera G, Bonfanti R (2024) Case report: A case of Rabson\u2013Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin. Front Genet 15:1414451. https:\/\/doi.org\/10.3389\/fgene.2024.1414451","journal-title":"Front Genet"},{"key":"2795_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000519613","volume":"94","author":"S Simaan dos Santos","year":"2021","unstructured":"Simaan dos Santos S, Ramaldes LA, Gabbay MAL, Moises RCS, Dib SA (2021) Use of a sodium-glucose cotransporter 2 inhibitor, empagliflozin, in a patient with Rabson-Mendenhall syndrome. Hormone Res Paediatrics 94:313\u2013316. https:\/\/doi.org\/10.1159\/000519613","journal-title":"Hormone Res Paediatrics"},{"key":"2795_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13340-024-00773-y","volume":"16","author":"Y Masunaga","year":"2025","unstructured":"Masunaga Y, Kinjo K, Murai Y, Fujisawa Y, Saitsu H, Ogata T (2025) Insulin resistant diabetes mellitus in a girl with mild Rabson-Mendenhall syndrome: efficacy of sodium glucose co-transporter 2 inhibitor. Diabetol Int 16:182\u2013187. https:\/\/doi.org\/10.1007\/s13340-024-00773-y","journal-title":"Diabetol Int"},{"issue":"9","key":"2795_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt A, Al-Hasani H (2020) Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Archiv - Eur J Physiol 472(9):1273\u20131298. https:\/\/doi.org\/10.1007\/s00424-020-02417-x","journal-title":"Pflugers Archiv - Eur J Physiol"},{"issue":"5","key":"2795_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1210\/endrev\/bnaa015","volume":"41","author":"I Hirsch","year":"2020","unstructured":"Hirsch I, Juneja R, Beals J, Antalis C, Wright E (2020) The evolution of insulin and how it informs therapy and treatment choices. Endocr Rev 41(5):733\u2013755. https:\/\/doi.org\/10.1210\/endrev\/bnaa015","journal-title":"Endocr Rev"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02795-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:48:26Z","timestamp":1788274106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":26,"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02795-1","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work involved retrospective analysis of a single de-identified clinical case and narrative review. Formal HREC review was considered exempt according to institutional guidance.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}